CYCCbenzinga

Cyclacel Pharmaceuticals Has Been Granted European Patent Number EP4013503 Titled CRYSTALLINE FORMS OF PYRIMIDINO DIAZEPINE DERIVATIVE (FOR THE TREATMENT OF PROLIFERATIVE DISORDERS SUCH AS CANCER, LEUKAEMIA, AND LYMPHOMA).

Summary

No summary available.

Original Article

Read the full article from the original source for complete details and context.

Read Full Article

Article published on April 24, 2025 by benzinga

    Cyclacel Pharmaceuticals Has Been Granted European Patent Number EP4013503 Titled CRYSTALLINE FORMS OF PYRIMIDINO DIAZEPINE DERIVATIVE (FOR THE TREATMENT OF PROLIFERATIVE DISORDERS SUCH AS CANCER, LEUKAEMIA, AND LYMPHOMA). | CYCC Stock News | Candlesense